Published Date:2021-06-16
Original Link:https://www.onenessbio.com/en/news_detail48_3.htm
| No | 1 | Date of announcement | 2021/06/16 | Time of announcement | 23:43:02 |
|---|---|---|---|---|---|
| Subject | Oneness Bio will hold the launch event and the medical symposium of Fespixon, the new drug for treating DFUs | ||||
| To which item it meets |
paragraph 12 | Date of events | 2021/07/04 | ||
| Statement | |||||
|
1.Date of institutional investor conference:2021/07/04
2.Time of institutional investor conference:14:00 3.Location of institutional investor conference: The launch event and medical symposium of Fespixon will be held virtually 4.Outline of institutional investor conference: The Company has scheduled to hold the launching event and the medical symposium of Fespixon on July 4, 2021, co-organized by the Diabetes Association of the Republic of China (Taiwan), Taiwan Society of Plastic Surgery, Taiwan Society for Wound Care, Taiwanese Association of Diabetes Educators, and Taiwan Society for Burn Injuries and Wound Healing. Medical professionals will be invited to join the medical symposium to discuss Fespixon, the new drug, and the diabetic foot ulcer management. The event will be held virtually via https://bit.ly/35sol9W for safety purpose during the pandemic. 5.Any other matters that need to be specified: (1)The presentation slides will be made publicly by being uploaded to Market Observation Post System according to the regulation. (2)The event will be proceeded according to the instructions from the Investor Conference FAQs and the regulatory authority. |
|||||